Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 16, Issue 9, Pages E646-E648Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2012.05.1029
Keywords
Providencia stuartii; Colistin; Tigecycline; Gram-negative bacteria; Antimicrobial resistance
Categories
Ask authors/readers for more resources
From 2005 to 2009, at Detroit Medical Center, the prevalence of Providencia stuartii increased from 0.52 to 0.91/1000 patient-days (p < 0.001). The use of colistin also increased (p < 0.001) during the study period. The increase in the prevalence of P. stuartii was associated with an increased use of colistin (p < 0.001). Facilities that frequently use colistin and tigecycline should closely monitor the prevalence of P. stuartii along with other Proteeae, since these organisms are intrinsically resistant to colistin and tigecycline. (c) 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available